Koa Shoji Holdings Co., Ltd. (JP:9273)
:9273
Top Page
Koa Shoji Holdings Co., Ltd.
(9273)
Select Model
Select Model
Rating:77Outperform
Price Target:
¥970.00
▲(14.25% Upside)
Action:ReiteratedDate:10/30/25
Koa Shoji Holdings Co., Ltd. demonstrates strong financial performance with robust growth and a solid balance sheet, which significantly contributes to its overall score. The stock's valuation is attractive, with a low P/E ratio and a reasonable dividend yield. However, technical indicators suggest a lack of bullish momentum, which slightly offsets the positive financial and valuation aspects.
Positive Factors
Conservative balance sheet
Extremely low leverage and a high equity ratio provide durable financial flexibility. This allows the company to fund operations, absorb shocks, pursue selective M&A or capex, and sustain dividends or buybacks without stressing solvency over the next several months.
Negative Factors
Business concentration
Heavy concentration in distribution of food and consumer products exposes the firm to sector-specific demand swings and intense competitive pricing. Over months this can limit diversification of revenue streams and make performance sensitive to retail/distribution cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage and a high equity ratio provide durable financial flexibility. This allows the company to fund operations, absorb shocks, pursue selective M&A or capex, and sustain dividends or buybacks without stressing solvency over the next several months.
Read all positive factors
Koa Shoji Holdings Co., Ltd. (9273) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥35.00B
Dividend Yield1.92%
Average Volume (3M)50.20K
Price to Earnings (P/E)7.5
Beta (1Y)0.78
Revenue Growth13.37%
EPS Growth19.73%
CountryJP
Employees289
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,119,980
10 Day Avg. Volume42,320
30 Day Avg. Volume50,200
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)1.04
Price to Sales (P/S)1.25
P/FCF Ratio15.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Koa Shoji Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells APIs/intermediates in Japan. It is also involved in the manufacture and marketing of various injections; OTC drugs, primarily various vitamins; and manufacture and sale of ge...
How the Company Makes Money
null...
Koa Shoji Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.27B | 22.13B | 22.05B | 20.35B | 17.82B |
| Gross Profit | 7.70B | 6.64B | 6.44B | 5.93B | 5.55B |
| EBITDA | 6.08B | 5.11B | 4.79B | 4.44B | 4.05B |
| Net Income | 3.64B | 2.95B | 2.69B | 2.36B | 2.14B |
Balance Sheet | |||||
| Total Assets | 36.11B | 32.00B | 28.46B | 26.25B | 24.80B |
| Cash, Cash Equivalents and Short-Term Investments | 14.92B | 13.95B | 10.77B | 9.12B | 8.26B |
| Total Debt | 2.46B | 2.84B | 3.18B | 3.56B | 3.94B |
| Total Liabilities | 7.99B | 6.95B | 7.54B | 7.58B | 8.10B |
| Stockholders Equity | 28.12B | 25.05B | 20.92B | 18.67B | 16.70B |
Cash Flow | |||||
| Free Cash Flow | 1.89B | 2.39B | 2.47B | 1.65B | 2.85B |
| Operating Cash Flow | 3.78B | 3.83B | 2.74B | 2.09B | 3.05B |
| Investing Cash Flow | -1.28B | -1.47B | -304.11M | -477.33M | -223.29M |
| Financing Cash Flow | -938.67M | 795.25M | -812.06M | -804.93M | -678.55M |
Koa Shoji Holdings Co., Ltd. Technical Analysis
Negative
849.00
Price Trends
853.58
Negative
834.50
Negative
791.90
Positive
Market Momentum
-9.65
Positive
45.07
Neutral
40.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9273, the sentiment is Negative. The current price of 849 is below the 20-day moving average (MA) of 860.25, below the 50-day MA of 853.58, and above the 200-day MA of 791.90, indicating a neutral trend. The MACD of -9.65 indicates Positive momentum. The RSI at 45.07 is Neutral, neither overbought nor oversold. The STOCH value of 40.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9273.
Koa Shoji Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥35.00B | 7.49 | ― | 1.92% | 13.37% | 19.73% | |
73 Outperform | ¥440.18B | 15.43 | 7.11% | 2.43% | 3.53% | 38.23% | |
73 Outperform | ¥124.89B | 12.60 | 4.81% | 2.34% | 4.35% | 48.30% | |
69 Neutral | ¥292.95B | 7.12 | 9.05% | 3.30% | 10.51% | 9.62% | |
59 Neutral | ¥224.80B | 13.89 | ― | 2.28% | 12.78% | -105.43% | |
58 Neutral | ¥308.91B | 9.20 | ― | 1.81% | 2.31% | 19.86% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:9273
Koa Shoji Holdings Co., Ltd.
831.00
118.13
16.57%
JP:4530
Hisamitsu Pharmaceutical Co
6,033.00
1,943.98
47.54%
JP:4540
Tsumura & Co
3,829.00
-501.96
-11.59%
JP:4534
Mochida Pharmaceutical Co., Ltd.
3,670.00
340.85
10.24%
JP:4887
SAWAI GROUP HOLDINGS Co., Ltd.
2,260.00
214.18
10.47%
JP:8129
Toho Holdings Co., Ltd.
4,731.00
280.70
6.31%
Koa Shoji Holdings Co., Ltd. Corporate Events
Koa Shoji Holdings Shifts Shareholder Registry to Sumitomo Mitsui Trust Bank
Feb 26, 2026
Koa Shoji Holdings has resolved to change its shareholder registry administrator and the account management institution for special accounts from Mitsubishi UFJ Trust and Banking Corporation to Sumitomo Mitsui Trust Bank, Limited. The change, effe...
Koa Shoji Lifts Dividend as Generics and Syringe Sales Drive Profit Growth
Feb 9, 2026
Koa Shoji Holdings reported first-half fiscal 2026 sales growth of 3.2% year-on-year and a 3.4% rise in operating profit, with progress toward full-year targets nearing half for sales and close to 60% for operating profit. Performance was supporte...
Koa Shoji Raises FY2026 Dividend Forecast, Signaling Stronger Shareholder Returns
Feb 9, 2026
Koa Shoji Holdings has raised its dividend forecast for the fiscal year ending June 30, 2026, reflecting its commitment to enhancing shareholder returns while maintaining sufficient internal reserves. The board approved increasing the planned annu...
Koa Shoji Posts Steady Interim Growth and Raises Dividend Forecast
Feb 9, 2026
Koa Shoji Holdings reported modest growth for the six months ended December 31, 2025, with net sales up 3.2% to ¥12.65 billion and profit attributable to owners of parent rising 1.8% to ¥2.08 billion. Earnings per share inched up to ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.